Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Specimen Handling 317Magnetic Resonance Spectroscopy 275pembrolizumab 268Carboplatin 190Cyclophosphamide 182Biopsy 175Cisplatin 164Gemcitabine 139Paclitaxel 137Bevacizumab 122fludarabine 119Nivolumab 115Radiotherapy 114Oxaliplatin 96venetoclax 94Fluorouracil 90Docetaxel 87Dexamethasone 86Capecitabine 86Drug Therapy 76Rituximab 74Pemetrexed 72Leucovorin 71durvalumab 70Radiosurgery 69Blood Specimen Collection 69Standard of Care 68Doxorubicin 64atezolizumab 62Radiation 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Clomiphene × 90 days × Clear all
NCT03059173 2026-04-22

MYOPK

University Hospital, Lille

Phase 3 Recruiting
276 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡